Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$21.1K Hold
58
﹤0.01% 408
2026
Q1
$20.5K Buy
58
+4
+7% +$1.43K 0.01% 364
2025
Q4
$17.7K Buy
54
+20
+59% +$6.34K 0.01% 367
2025
Q3
$9.6K Hold
34
﹤0.01% 462
2025
Q2
$9.49K Hold
34
﹤0.01% 456
2025
Q1
$10.6K Hold
34
﹤0.01% 429
2024
Q4
$8.86K Hold
34
﹤0.01% 456
2024
Q3
$11K Hold
34
﹤0.01% 420
2024
Q2
$10.6K Hold
34
﹤0.01% 406
2024
Q1
$9.67K Hold
34
0.01% 450
2023
Q4
$9.79K Buy
+34
New +$9.26K 0.01% 426

Other funds holding AMGN

Tidemark's AMGN Position: Q2 2026 in Review

Tidemark held its Amgen (AMGN) position steady in Q2 2026 at 58 shares worth $21.1K. The position accounts for ﹤0.01% of the portfolio, ranked #408.

Tidemark first reported a position in AMGN in Q4 2023 and has held it in 11 quarters since. 3,158 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Tidemark held 58 shares of Amgen worth $21.1K as of Q2 2026.
  • Tidemark left its Amgen share count unchanged in Q2 2026.
  • Amgen made up ﹤0.01% of Tidemark's portfolio in Q2 2026, its #408 holding.
  • Tidemark first reported a position in Amgen in Q4 2023 and has held it in 11 quarters since.
  • 3,158 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Tidemark's 13F filing for Q2 2026, filed 10 Aug 2026.